Haemostasis and thrombosis Flashcards

1
Q

What is appropriate coagulation?

A

Haemostasis:
primary haemostasis
secondary haemostasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is inappropriate coagulation?

A

Thrombosis:
arterial
venous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What happens when you have an injury?

A
Vessel injury
-platelet adhesion
platelet aggregation
-activation of coagulation cascade
fibrin formation 
*haemostatic plug 
fibrinolytic activity 
repair of vessel damage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What occurs in primary haemostasis?

A

when vessel wall is injured- exposes collagen

platelets stick to the collagen via von Willebrand factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Types of platelet bleeding disorder and treatment used

A
  • Due to a reduced number of platelets- inherited of acquired
  • Due to abnormal function- can be inherited or acquire d (antiplatelet drugs used for thrombosis etc)
  • tretament= platelet transfusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is Von Willebrand disease and what are its symptoms?

A

VWFs are missing- a common bleeding disorder
autosomal dominant
3 subtypes
milder bleeding than in haemophilia
main symptom= heavy periods
also:
bruising, cuts, gum bleeding, nose bleeds, post operative bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do you treat Von Willebrand disease?

A
  1. Intermediate purity factor 8 (plasma derived)

2. Desmopressin- makes the body release VWF from endothelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Examples of coagulation factor disorders

A

Haemophilia a= factor 8 deficiency
Haemophilia b= factor 9 deficiency
-others- deficiency of fibrinogen, factor 2,5,7,10
*just giving plasma isnt ideal- need a more precise treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the symptoms of heamophilia?

A

clinical features of a & b is the same
sites of bleeding: joints, muscles, post trauma, postoperative
bleed into joint= hemarthrosis- lots of bleeds- erodes cartilage- bone on bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do we make clotting factor concentrates?

A

Plasma derived
Made using recombinant technology
-not enough demand to make all the clotting factors via recombinant technology (factor 5 etc.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the treatments for primary haemostasis?

A

Platelet transfusion
demsopressin
VWF concentrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the treatments for secondary haemostasis?

A

Specific clotting factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the 2 types of thrombosis and what are their characteristics? What are their clinical presentations?

A
Arterial
-high-pressure system 
-platelet rich
myocardial infarction, thrombotic stroke 
Venous
-low pressure 
-fibrin rich- problem on coagulation cascade 
DVT, pulmonary embolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How are the 2 types of thrombosis treated?

A

Arterial- antiplatelet drugs

Venous- anticoagulant drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Examples of antiplatelet drugs

A

used to be: aspirin and clopidogrel

prasugrel, ticagrelor, cangrelor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the 3 types of anticoagulant drugs, examples of each type

A

Intravenous- unfractionated heparin
subcutaneous- low MW heparin
oral- warfarin
direct oral anticoagulants- dabigatran, rivaroxaban, apixaban, edoxaban

17
Q

How does heparin work?

A

Binds to and activates antithrombin-

inhibits the coagulation cascade more efficiently

18
Q

How is glycosaminoglycan antithrombotic?

A

Indirectly inhibits thrombin
effects anti thrombin
monitored with APTT test
given by continuous infusion

19
Q

What is low molecular weight heparin, when is it used?

A

Smaller molecule made from heparin- easier for body to take
given subcutaneously
renally excreted
weight based
given once daily
-can be used as a treatment or in preventing thrombosis
-in hospital, over 45 years old, thrombosis risk high enough= put on this drug

20
Q

What the pharmacology of warfarin?

A
Completely and rapidly absorbed 
inhibits vitamin K dependent clotting factors 
slow on and off action 
warfarin inhibits factors: 2,7,9 and 10
side fx:
bleeding and embryopathy
21
Q

How is warfarin monitored?

A

test used to monitor the effect of warfarin= international normalized ration
dose based on INR
frequency of monitoring depends on INR
blood test every week/ 8 weeks for rest of life
NO single dose for every person= personalised medicine
dose you need is genetically controlled

22
Q

What is the cyclin involving s-warfarin, VKOR and GGCX?

A

Hypofunctional factors need to be carboxylated by the enzyme GGCX
GGCX requires vitamin k- when vitamin k is activated it is oxidized
VKOR recycles reduced vitamin K
S-warfarin inhibits VKOR- GGCX doesn’t work- clothing factors remain hypofunctional
CYP2C9 breaks down warfarin

23
Q

Which 3 enzymes control your warfarin dose?

A

VKOR
GGCX
CYP2C9

24
Q

How do people differ in warfarin digestion?

A

Some people break down warfarin rapidly, others dont
if we could identify the polymorphisms in the enzymes-
could work out the dose youd need

25
Characteristics of DOACs?
``` Direct oral anticoagulants no monitoring needed* oral aiming to replace heparin and warfarin no alcohol/food interactions standard dosing* very few drug interactions short half life more expensive than warfarin ```
26
Examples of DOACS
``` Targeting factor Xa: rivaroxaban apixaban edoxaban Targeting factor 2a: dabigatran -They're new drugs- currently going through clinical trials ```
27
Can you reverse the actions of DOACS?
Currently only dabigatran | via humanised monoclonal antibody= idarucizumab
28
Advantages of DOACs?
rapid onset of action fixed oral dosing with predictable coagulant effects low potential for food/alcohol interactions low potential for drug interactions no need for blood monitoring
29
Disadvantages of DOACs?
Renal elimination no specific antidotes for the Xa inhibitors licensed for only specific indications recently introduced